Inhibition of mesangial cell proliferation by platelet factor 4

Journal of the American Society of Nephrology

Volumn 7, Issue 7, 1996, Pages 991-998

  Barnes, Jeffrey L ^a,b,d   Woodruff, Katherine A ^a   Levine, Shirley P ^c   Abboud, Hanna E ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Mesangial cells; Platelet factor 4; Platelet derived growth factor; Proliferation

Indexed keywords

DNA; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR RECEPTOR; THROMBOCYTE FACTOR 4; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; AUTORADIOGRAPHY; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; DNA SYNTHESIS; HUMAN; HUMAN CELL; MESANGIUM CELL; MITOGENESIS; NORTHERN BLOTTING; PRIORITY JOURNAL; RECEPTOR BINDING; THROMBOCYTE;

EID: 0030357601     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Barnes JL. Platelets in renal diseases. In: Tetta C, Ed. Handbook of Immunopharmocology: Immunopharmocology of the Renal System. London: Academic Press; 1993:88-118.
2. Abboud HE: Growth factors and the mesangium. J Am Soc Nephrol 1992;2:S185-S189.
3. Fine LG, Hammerman MR, Abboud HE: Evolving role of growth factors in the renal response to acute and chronic disease [Editorial]. J Am Soc Nephrol 1992;2:1163-1170.
4. Levine SP, Wohl H: Human platelet factor 4: Purification and characterization by affinity chromatography. Purification of human platelet factor 4. J Biol Chem 1976;251:324-328.
5. Zucker MB, Katz IR: Platelet factor 4: Production, structure, and physiologic and immunologic action. Proc Soc Exp Biol Med 1991;198:693-702.
6. Barber AJ, Kaser-Glanzmann R, Jakábová M, Loscher EF: Characterization of a chondroitin 4-sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4) released from human blood platelets. Biochim Biophys Acta 1972;286:312-329.
7. Handin RI, Cohen HJ: Purification and binding properties of human platelet factor four. J Biol Chem 1976;251:4273-4282.
8. Busch C, Dawes J, Pepper DS, Wasteson A: Binding of platelet factor 4 to cultured human umbilical vein endothelial cells. Thromb Res 1980;19:129-137.
9. Rybak ME, Gimbrone MA Jr, Davies PF, Handin RI: Interaction of platelet factor four with cultured vascular endothelial cells. Blood 1989;73:1534-1539.
10. Barnes JL, Levine SP, Venkatachalam MA: Binding of platelet factor four (PF 4) to glomerular polyanion. Kidney Int 1984;25:759-765.
11. Wu V-Y, Cohen MP: Platelet factor 4 binding to glomerular microvascular matrix. Biochim Biophys Acta 1984;797:76-82.
12. Barnes JL: Glomerular localization of platelet secretory proteins in mesangial proliferative lesions induced by habu snake venom. J Histochem Cytochem 1989;37:1075-1082.
13. Barnes JL, Camussi G, Tetta C, Venkatachalam MA: Glomerular localization of platelet cationic proteins after immune complex-induced platelet activation. Lab Invest 1990;63:755-761.
14. Duffus P, Parbtani A, Frampton G, Cameron JS: Intraglomerular localization of platelet related antigens, platelet factor 4 and β-thromboglobulin in glomerulonephritis. Clin Nephrol 1982;17:288-297.
15. Fritschi J, Christe M, Lamblia B, Marbet GA, Berger W, Duckert F: Platelet aggregation, β-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy. Thromb Haemostasis 1984;52:236-239.
16. Mezzano S, Burgos ME, Ardues L, et al.: Glomerular localization of platelet factor 4 in streptococcal nephritis. Nephron 1992;61:58-63.
17. Goldberg ID, Stemerman MB, Handin RI: Vascular permeation of platelet factor 4 after endothelial injury. Science (Wash DC) 1980;209:611-612.
18. Shultz PJ, DiCorleto PE, Silver BJ, Abboud HE: Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 1988;255:F674-F684.
19. Silver BJ, Jaffer FE, Abboud HE: Platelet-derived growth factor synthesis in mesangial cells: Induction by multiple peptide mitogens. Proc Natl Acad Sci USA 1989;86:1056-1060.
20. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4354.
21. Johnson RJ, Iida H, Alpers CE, et al.: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis: α-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 1991;87:847-858.
22. Voyta JC, Via DP, Butterfield CE, Zetter BR: Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984;99:2034-2040.
23. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-5299.
24. Betsholtz C, Johnsson A, Heldin C-H, et al.: cDNA sequence and chromosomal localization of human platelet-derived growth factor-A chain and its expression in tumor cell lines. Nature (Lond) 1986;320:695-699.
25. Derynck R, Jarrett JA, Chen EY, et al.: Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature (Lond) 1985;316:701-705.
26. Basset P, Bellocq JP, Wolf C, et al.: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond) 1990;348:699-704.
27. Gewirtz AM, Calabretta B, Rucinski B, Niewiarowski S, Xu WY: Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest 1989;83:1477-1486.
28. Han ZC, Sensebe L, Abgrall JF, Brière J: Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood 1990;75:1234-1239. s
29. Maione TE, Gray GS, Hunt AJ, Sharpe RJ: Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res 1991;51:2077-2083.
30. Maione TE, Gray GS, Petro J, et al.: Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science (Wash DC) 1990;247:77-79.
31. Gupta SK, Singh JP: Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. J Cell Biol 1994;127:1121-1127.
32. Watson JB, Getzler SB, Mosher DF: Platelet factor 4 modulates the mitogenic activity of basic fibroblast growth factor. J Clin Invest 1994;94:261-268.
33. Tatakis DN: Human platelet factor 4 is a direct inhibitor of human osteoblast-like osteosarcoma cell growth. Biochem Biophys Res Commun 1992;187:287-293.
34. Kolber DL, Knisely TL, Maione TE: Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J Natl Cancer Inst 1995;87:304-309.
35. Schlondorff D: The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB (Fed Am Soc Exp Biol) J 1987;1:272-281.
36. Abboud HE, Woodruff KA, Snyder SP, Bonewald LF: Polypeptide growth factors regulate the production of latent transforming growth factor β in human mesangial cells [Abstract]. J Am Soc Nephrol 1991;2:434A.
37. Kaname S, Uchida S, Ogata E, Kurokawa K: Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells. Kidney Int 1992;42:1319-1327.
38. Sato Y, Abe M, Takaki R: Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. Biochem Biophys Res Commun 1990;172:595-600.
39. Whitson RH Jr, Wong WL, Itakura K: Platelet factor 4 selectively Inhibits binding of TGF-beta 1 to the type I TGF-beta 1 receptor. J Cell Biochem 1991;47:31-42.
40. Karin M: Signal transduction from cell surface to nucleus in development and disease. FASEB (Fed Am Soc Exp Biol) J 1992;6:2581-2590.
41. Travail S, Koniecki J, Petralia S, Baserga R: Oncogenes in growth and development. FASEB (Fed Am Soc Exp Biol) J 1990;4:3209-3214.
42. Klagsbrun M: Regulators of angiogenesis: Stimulators, inhibitors, and extracellular matrix. J Cell Biochem 1991;47:199-200.
43. Munro JM, Cotran RS: Biology of Disease. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest 1988;58:249-261.
44. Deuel TF, Senior RM, Chang D, Griffin GL, Heinrikson RL, Kaiser ET: Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 1981;78:4584-4587.
45. Senior RM, Griffin GL, Huang JS, Walz DA, Deuel TF: Chemotactic activity of platelet alpha granule proteins for fibroblasts. J Cell Biol 1983;96:382-385.
46. Sharpe RJ, Murphy GF, Witaker D, Galli SJ, Maione TE: Induction of local inflammation by recombinant human platelet factor 4 in the mouse. Cell Immunol 1991;137:72-80.
47. Bruijnzeel PLB, Kuijper PHM, Rihs S, Betz S, Warringa RAJ, Koenderman L: Eosinophil migration in atopic dermatitis I: Increased migratory responses to N-formylmethionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet activating factor, and platelet factor 4. J Invest Dermatol 1993;100:137-144.
48. Barnes JL, Hevey KA: Glomerular mesangial cell migration: Response to platelet secretory products. Am J Pathol 1991;138:859-866.